Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy

NCT02262832 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT02262832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02262832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 9, 2014
Completion date
July 31, 2027
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hyperlipidemia, lipodystrophy